Latest News and Press Releases

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V:...

SUWANEE, Ga., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Twissted Whiskers Pet Hotel has announced the expansion of its daycare capacity in response to a marked increase in pet-care demand across the Suwanee...

Heineken 0.0 Zero Judgement A Media Snippet accompanying this announcement is available by clicking on this link. AMSTERDAM, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The World has...

DENVER, Dec. 03, 2025 (GLOBE NEWSWIRE) -- SMG is about to complete its Initial Public Offering (IPO), marking an important milestone in the company’s development and signaling the official beginning...

Pivotal Phase 3 randomized, double-blind, placebo-controlled study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac endpoint (LVEF), both achieving statistical significance...

Advertisement THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM CANADA, SWITZERLAND OR INDIA OR ANY OTHER JURISDICTION...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

BOULDER, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- TESSAN, a provider of global power and charging technology, today announced the launch of the TESSAN Voyager 205, a next-generation universal travel...

Silevertinib delivers robust anti-tumor activity as demonstrated by an ORR of 60% and a CNS response rate of 86% in 43 1L NSCLC patients presenting with 35 different non-classical EGFR mutations; no...